{"name":"Azienda Usl di Bologna","slug":"azienda-usl-di-bologna","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Blood transfusions","genericName":"Blood transfusions","slug":"blood-transfusions","indication":"Other","status":"phase_2"},{"name":"Drugs administration","genericName":"Drugs administration","slug":"drugs-administration","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Blood transfusions","genericName":"Blood transfusions","slug":"blood-transfusions","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Drugs administration","genericName":"Drugs administration","slug":"drugs-administration","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBNU21CNHJnX0xlNWx4X2NXNjRfa1hNWXd5TmRXY0dYWXlmSVdhVFAxS0x4MHVTdU9Wa3ZSYU1oOVJGRm8tTEJYM2ZIS09weFRFdjV2RnRKT2RHeGdxT0lZ?oc=5","date":"2018-03-13","type":"pipeline","source":"Nature","summary":"Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1 - Nature","headline":"Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}